Answers are grounded in this paper and cite their sources.
Background: Metabolic surgery for the treatment of type 2 diabetes patients, with body mass index (BMI) less than 35 kg/m 2 has been found to be increasing every year. Duodenoileal interposition with sleeve gastrectomy and transit bipartition (TB) has strong effects on control of type 2 diabetes mellitus. However, both procedures may have long-term problems. Due to duodenal exclusion, endoscopic evaluation of the duodenum and biliary tract becomes impossible after duodenoileal interposition. The TB may have the risk of severe malabsorption due to enlargement of the gastroileostomy. We performed ileal interposition and TB in patients with class 1 obesity having type 2 diabetes, with ethical approval. The new modification included in this paper, was performed in 3 patients, one of whom had a BMI of 30 kg/m 2 . The aim of this innovation is to treat obese (BMI >30 kg/m 2 ), type 2 diabetes patients with an effective, but less malabsorptive procedure.
No takes yet. Share an insight, caveat, or question.
Demirel et al. (2017) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: